521 Phase II studies of Nivolumab in patients with Advanced Squamous (SQ) or Non-Squamous (NSQ) Non-Small Cell Lung Cancer (NSCLC). (September 2015) - Sakai, H.; Nishio, M.; Hida, T.; Nakagawa, K.; Nogami, N.; Atagi, S.; Takahashi, T.; Nokihara, H.; Saka, H.; Takenoyama, M.; Fujita, S.; Tanaka, H.; et al.